TLRY 1.26 (+8.62%)
US88688T1007Drug ManufacturersDrug Manufacturers - Specialty & Generic

Tilray Brands (TLRY) Financial Metrics

This table shows a selected set of financial data points of Tilray Brands (TLRY). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2024 -0.33 0 -3.82 935.74M -0.06 788.94M -60.15M -47.8M -244.98M 228.34M
2023 -2.37 0 -0.97 1.41B -0.3 627.12M -12.89M -312.97M -1.45B 206.63M
2022 -0.99 0 -2.72 1.3B -0.08 628.37M -211.33M 101.94M -476.8M 415.91M
2021 -0.82 0 -8.54 3.14B -0.09 513.09M -83.59M -159.17M -367.42M 488.47M
2020 -0.47 0 -17.41 1.79B -0.06 405.33M -199.41M -30.19M -102.54M 360.65M
2019 -0.12 0 -139.16 3.49B -0.02 179.3M -193.33M 14.36M -25.04M 407.5M
2018 -0.32 0 -219.14 14.84B -0.19 43.13M -100.71M -59.5M -67.72M 487.26M
2017 -0.04 0 0 0 -0.18 20.54M -17.44M -4.27M -7.81M 2.32M
2016 -0.07 0 0 0 0 12.64M -62.4M 6.66M -7.88M 7.53M

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.